A TRIAL OF NONSPECIFIC IMMUNOTHERAPY USING SYSTEMIC C-PARVUM IN TREATED PATIENTS WITH DUKES B AND C COLORECTAL-CANCER

被引：15
|
作者：
SOUTER, RG
GILL, PG
MORRIS, PJ
机构：
来源：
BRITISH JOURNAL OF CANCER | 1982年 / 45卷 / 04期
关键词：
D O I：
10.1038/bjc.1982.86
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：506 / 512
页数：7
相关论文
共 50 条
  • [31] Prognastic values of micrornas in patients with Dukes' B and C colon cancer
    Karaayvaz, M.
    Pal, T.
    Song, B.
    Zhang, C.
    Geogakopoulos, P.
    Mehmood, S.
    Burke, S.
    Shroyer, K.
    Ju, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
    Rosati, G.
    Ambrosini, G.
    Barni, S.
    Andreoni, B.
    Corradini, G.
    Luchena, G.
    Daniele, B.
    Gaion, F.
    Oliverio, G.
    Duro, M.
    Martignoni, G.
    Pinna, N.
    Sozzi, P.
    Pancera, G.
    Solina, G.
    Pavia, G.
    Pignata, S.
    Johnson, F.
    Labianca, R.
    Apolone, G.
    Zaniboni, A.
    Monteforte, M.
    Negri, E.
    Torri, V.
    Mosconi, P.
    Fossati, R.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 274 - 280
  • [33] Prediction of recurrence in Dukes B colorectal cancer patients using molecular profiling
    Skarlas, Lambros
    Antonacopoulou, Anna
    Likothanassis, Spiridon
    Kalofonou, Melpomeni
    Kalofonos, Haralabos
    ANNALS OF ONCOLOGY, 2006, 17 : 252 - 252
  • [34] ACTIVE, SPECIFIC IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR-CELLS ADMIXED WITH C-PARVUM IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    KURTH, KH
    MARQUET, R
    JONAS, U
    WARNAAR, SD
    PROSTATE, 1983, 4 (06): : 660 - 661
  • [35] FAMILY HISTORY OF CANCER, BODY-WEIGHT, AND P53 NUCLEAR OVEREXPRESSION IN DUKES-C COLORECTAL-CANCER
    ZHANG, ZF
    ZENG, ZS
    SARKIS, AS
    KLIMSTRA, DS
    CHARYTONOWICZ, E
    POLLACK, D
    VENA, J
    GUILLEM, J
    MARSHALL, JR
    CORDONCARDO, C
    COHEN, AM
    BEGG, CB
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 888 - 893
  • [36] TIME TO LOCO-REGIONAL RECURRENCE AFTER RESECTION OF DUKES-B AND DUKES-C COLORECTAL-CANCER WITH OR WITHOUT ADJUVANT POSTOPERATIVE RADIOTHERAPY - A MULTIVARIATE REGRESSION-ANALYSIS
    BENTZEN, SM
    BALSLEV, I
    PEDERSEN, M
    TEGLBJAERG, PS
    HANBERGSORENSEN, F
    BONE, J
    JACOBSEN, NO
    SELL, A
    OVERGAARD, J
    BERTELSEN, K
    HAGE, E
    FENGER, C
    KRONBORG, O
    HANSEN, L
    HOSTRUP, H
    NORGAARDPEDERSEN, B
    BRITISH JOURNAL OF CANCER, 1992, 65 (01) : 102 - 107
  • [37] A RANDOMIZED PROSPECTIVE CLINICAL-TRIAL OF ADJUVANT C-PARVUM IMMUNOTHERAPY IN 260 PATIENTS WITH CLINICALLY LOCALIZED MELANOMA (STAGE-1) - PROGNOSTIC FACTORS ANALYSIS AND PRELIMINARY-RESULTS OF IMMUNOTHERAPY
    BALCH, CM
    SMALLEY, RV
    BARTOLUCCI, AA
    BURNS, D
    PRESANT, CA
    DURANT, JR
    CANCER, 1982, 49 (06) : 1079 - 1084
  • [38] HIGH-DOSE METHOTREXATE WITH RESCUE PLUS CYCLOPHOSPHAMIDE AS INITIAL CHEMOTHERAPY IN OVARIAN ADENOCARCINOMA - A RANDOMIZED TRIAL WITH OBSERVATIONS ON THE INFLUENCE OF C-PARVUM IMMUNOTHERAPY
    BARLOW, JJ
    PIVER, MS
    LELE, SB
    CANCER, 1980, 46 (06) : 1333 - 1338
  • [39] Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer
    Focan, C
    Bury, J
    Beauduin, M
    Herman, ML
    Vindevoghel, A
    Lecomte, M
    Brohée, D
    Canon, JL
    Focan-Henrard, D
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4665 - 4672
  • [40] Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis
    Diamantis, N.
    Xynos, I. D.
    Amptulah, S.
    Karadima, M.
    Skopelitis, H.
    Tsavaris, N.
    JOURNAL OF BUON, 2013, 18 (01): : 105 - 115
12345